Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. KFY
5. ABBV
6. MU
7. DPZ
8. NAVN
9. DFTX
10. NVEC

Go back to Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte (INCY) Tops Q2 EPS by 5c

August 3, 2021 7:22 AM EDT

Incyte (NASDAQ: INCY) reported Q2 EPS of $0.80, $0.05 better than the analyst estimate of $0.75. Revenue for the quarter came in at $705.7 million versus the consensus estimate of $686.98... More